Your browser doesn't support javascript.
loading
Successful treatment of duodenal myeloid sarcoma with allogeneic bone marrow transplantation and additional radiotherapy.
Yagi, Toshinari; Ishikawa, Jun; Takahashi, Masahumi; Yamashita, Yukiko; Kusakabe, Shinsuke; Yoshinami, Tetsuhiro; Masaie, Hiroaki; Sugimoto, Naotoshi; Yoshida, Hitoshi; Imamura, Fumio.
Affiliation
  • Yagi T; Department of Clinical Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan. yagi-to@mc.pref.osaka.jp
Intern Med ; 51(7): 769-72, 2012.
Article in En | MEDLINE | ID: mdl-22466836
Myeloid sarcoma (MS) is a tumor consisting of myeloid blasts that occurs at an anatomical site other than the bone marrow. We report the case of a 38-year-old man with duodenal MS who underwent an allogeneic bone marrow transplant in a non-complete remission (CR) state. After the transplant, residual disease was suspected on a fluorodeoxyglucose positron emission tomography (FDG-PET)/CT scan, and additional radiotherapy resulted in CR, which has been maintained for 21 months. FDG-PET/CT scanning is useful for evaluating residual myeloid sarcoma during the peritransplant period.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Myeloid / Duodenal Neoplasms Limits: Adult / Humans / Male Language: En Journal: Intern Med Journal subject: MEDICINA INTERNA Year: 2012 Document type: Article Affiliation country: Japan Country of publication: Japan
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Myeloid / Duodenal Neoplasms Limits: Adult / Humans / Male Language: En Journal: Intern Med Journal subject: MEDICINA INTERNA Year: 2012 Document type: Article Affiliation country: Japan Country of publication: Japan